Publications:

Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells.

Oncotarget

Zemanova, Jana J; Hylse, Ondrej O; Collakova, Jana J; Vesely, Pavel P; Oltova, Alexandra A; Borsky, Marek M; Zaprazna, Kristina K; Kasparkova, Marie M; Janovska, Pavlina P; Verner, Jan J; Kohoutek, Jiri J; Dzimkova, Marta M; Bryja, Vitezslav V; Jaskova, Zuzana Z; Brychtova, Yvona Y; Paruch, Kamil K; Trbusek, Martin M

Publication Date: 2016-09-20

Variant appearance in text: TP53: 816_841del

PubMed Link: 27556692

Variant Present in the following documents:

• Main text
• oncotarget-07-62091.pdf

View BVdb publication page